Results 31 to 40 of about 596 (171)
Bizarre Complications of Peritoneovenous Shunts
Implantable peritoneovenous shunts have facilitated the management of patients with medically intractable ascites. The more commonly reported complications occur with an incidence of 20-50%. Rare and problematic complications are becoming increasingly frequent.
F E, Eckhauser +3 more
openaire +3 more sources
Percutaneous peritoneovenous shunt positioning: technique and preliminary results
Nine peritoneovenous shunts were positioned by percutaneous technique in seven patients with advanced malignancy causing severe refractory ascites, and in two patients with hepatic cirrhosis (one with hepatocarcinoma).
R. F. Grasso +5 more
core +1 more source
Palliative Treatment of Malignant Refractory Ascites by Positioning of Denver Peritoneovenous Shunt
Malignant ascites is relatively common in patients with certain types of end-stage cancer. Traditional treatments based on fluid and salt restriction and diuretic therapy often are not able to contain neoplastic ascites.
Maurizio Grosso +7 more
core +1 more source
Management of portal hypertension and ascites in polycystic liver disease
Abstract Patients suffering from polycystic liver disease may develop Hepatic Venous Outflow Obstruction, Portal Vein Obstruction and/or Inferior Caval Vein Syndrome because of cystic mass effect. This can cause portal hypertension, leading to ascites, variceal haemorrhage or splenomegaly.
Lucas H. P. Bernts +2 more
wiley +1 more source
PARPi Combining Nanoparticle LIN28B siRNA for the Management of Malignant Ascites
This study demonstrates that co‐inhibition of LIN28B and PARP using siLin28b/DSSP@lip‐PEG‐FA nanoparticles in combination with the PARP inhibitor BMN673 effectively suppresses the accumulation of malignant ascites associated with advanced cancers.
Yan Fang +13 more
wiley +1 more source
Objective(s). Malignant ascites (MA) is abnormal accumulation of fluid in the peritoneal cavity and has negative effects on the quality of life. The purpose of this retrospective study is to explore feasibility, safety and efficacy of tunneled peritoneal catheter placement using both peritoneal dialysis and hemodialysis catheters in the palliation of ...
Ahmet Kaya +3 more
wiley +1 more source
Current treatment options of refractory ascites in liver cirrhosis - A systematic review and meta-analysis. [PDF]
BACKGROUND Refractory ascites is a severe complication of liver cirrhosis and treatment options consist in large volume paracentesis, transjugular intrahepatic portosystemic shunt, alfapump®, peritoneovenous shunt and permanent indwelling peritoneal ...
Berzigotti, Annalisa +2 more
core +1 more source
Cell‐free and concentrated ascites reinfusion therapy had lower mortality and in‐hospital costs than paracentesis in metastatic cancer, particularly in males, patients with serum albumin ≤ 2.5 g/dL, and those with non‐gastrointestinal cancer. ABSTRACT Background Paracentesis temporarily relieves malignant ascites but causes hypoalbuminemia.
Yuki Hashimoto +2 more
wiley +1 more source
Chyle leaks may occur as a result of surgical intervention. Chyloperitoneum, or chylous ascites after liver transplantation, is rare and the development of chylothorax after abdominal surgery is even more rare. With increasingly aggressive surgical resections, particularly in the retroperitoneum, the incidence of chyle leaks is expected to increase in ...
Tommy Ivanics +9 more
wiley +1 more source
Peritoneovenous Shunt Occlusion
Electronic pressure testing of every LeVeen valve has practically eliminated mechanical malfunction as a cause of shunt failure. Nonetheless, failures do occur and in a series of 240 cases, early or late shunt failure occurred in 29 patients. Thirty-five additional cases of failures were either referred by other physicians over a period of 6 years or ...
H H, LeVeen +3 more
openaire +3 more sources

